misonidazole has been researched along with Necrosis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatanaka, KC; Hirata, K; Kobayashi, H; Kobayashi, K; Kuge, Y; Manabe, O; Shiga, T; Tamaki, N; Terasaka, S; Toyonaga, T; Watanabe, S; Yamaguchi, S; Yuzawa, S | 1 |
| Partridge, M; Warren, DR | 1 |
| Alessio, AM; Alvord, EC; Anderson, AR; Chakraborty, G; Champley, K; Claridge, J; Gu, S; Kinahan, PE; Krohn, KA; Muzi, M; Rockne, R; Spence, AM; Swanson, KR | 1 |
| Civelek, AC; Huang, T; Jiang, H; Li, J; Li, XF; Ng, CK; Postel, GC; Shen, B | 1 |
| Aigbirhio, FI; Baron, JC; Beech, JS; Clark, JC; Fryer, TD; Hong, YT; Hughes, JL; Igase, K; Jones, PS; Menon, DK; Smith, R; Takasawa, M | 1 |
| Hendry, JH; Sutton, ML | 1 |
| Dische, S; Minchinton, A; Rich, TA; Saunders, MI; Stratford, MR | 1 |
| Bennett, MH; Dische, S; Hauck, J; Minchinton, AI; Riley, PJ; Saunders, MI; Stratford, MR | 1 |
| Allalunis-Turner, MJ; Franko, AJ; Mercer, JR; Mielke, BW; Parliament, MB; Santos, CL; Wolokoff, BG | 1 |
| Allalunis-Turner, MJ; Franko, AJ; Parliament, MB; Wolokoff, BG | 1 |
| Curry, B; Feldstein, M; Fulton, DS; Hanson, J; Huyser-Wierenga, D; Johnson, ES; Mielke, B; Scott-Brown, I; Urtasun, RC | 1 |
1 trial(s) available for misonidazole and Necrosis
| Article | Year |
|---|---|
Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study.
Topics: Adolescent; Adult; Age Factors; Aged; Astrocytoma; Brain; Brain Neoplasms; Cobalt Radioisotopes; Combined Modality Therapy; Cranial Irradiation; Dose-Response Relationship, Radiation; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Misonidazole; Multivariate Analysis; Necrosis; Proportional Hazards Models; Radiation Injuries; Radioisotope Teletherapy; Radiotherapy Dosage; Severity of Illness Index; Skin Diseases; Survival Analysis; Survival Rate; Treatment Outcome | 1992 |
10 other study(ies) available for misonidazole and Necrosis
| Article | Year |
|---|---|
(18)F-fluoromisonidazole positron emission tomography can predict pathological necrosis of brain tumors.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Cerebellum; Female; Humans; Male; Middle Aged; Misonidazole; Necrosis; Positron-Emission Tomography | 2016 |
The role of necrosis, acute hypoxia and chronic hypoxia in
Topics: Computer Simulation; Humans; Hypoxia; Misonidazole; Models, Theoretical; Necrosis; Neoplasms; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Spheroids, Cellular | 2016 |
Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET images.
Topics: Adult; Brain Neoplasms; Cell Proliferation; Computer Simulation; Fluorine Radioisotopes; Glioblastoma; Glioma; Humans; Hypoxia; Image Interpretation, Computer-Assisted; Male; Mathematical Concepts; Misonidazole; Models, Biological; Necrosis; Neoplasm Invasiveness; Neovascularization, Pathologic; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals; User-Computer Interface | 2012 |
Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer.
Topics: Animals; Biological Transport; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Misonidazole; Necrosis; Nitroimidazoles; Pilot Projects; Positron-Emission Tomography; Radioactive Tracers; Tumor Microenvironment | 2012 |
Imaging of brain hypoxia in permanent and temporary middle cerebral artery occlusion in the rat using 18F-fluoromisonidazole and positron emission tomography: a pilot study.
Topics: Anesthesia; Animals; Hypoxia, Brain; Image Interpretation, Computer-Assisted; Infarction, Middle Cerebral Artery; Kinetics; Ligation; Male; Middle Cerebral Artery; Misonidazole; Models, Biological; Necrosis; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Inbred SHR; Stroke | 2007 |
On the sensitisation of skin radionecrosis in mice by misonidazole at low doses.
Topics: Animals; Dose-Response Relationship, Radiation; Female; Mice; Misonidazole; Necrosis; Nitroimidazoles; Radiation Dosage; Radiation Injuries, Experimental; Skin | 1984 |
A serial study of the concentration of misonidazole in human tumors correlated with histologic structure.
Topics: Adenocarcinoma; Biopsy; Breast Neoplasms; Female; Humans; Male; Misonidazole; Necrosis; Nitroimidazoles; Radiotherapy Dosage | 1981 |
The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid.
Topics: Breast Neoplasms; Female; Humans; Misonidazole; Necrosis; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors; Uterine Cervical Neoplasms | 1981 |
Anomalous patterns of nitroimidazole binding adjacent to necrosis in human glioma xenografts: possible role of decreased oxygen consumption.
Topics: Animals; Antineoplastic Agents; Autoradiography; Binding Sites; Cell Line; Glioblastoma; Glioma; Humans; Hypoxia; Mice; Mice, SCID; Misonidazole; Necrosis; Oxygen Consumption; Rats; Rats, Nude; Transplantation, Heterologous; Tritium; Tumor Cells, Cultured | 1997 |
Variable presence of hypoxia in M006 human glioma spheroids and in spheroids and xenografts of clonally derived sublines.
Topics: Animals; Brain Neoplasms; Clone Cells; Deuterium; Glioma; Humans; Hypoxia; Mice; Mice, SCID; Misonidazole; Necrosis; Radiation-Sensitizing Agents; Spheroids, Cellular; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |